Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. A. Duncan
Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Efficacy and Safety of Monotherapy by Pegvisomant, a Growth Hormone Receptor Antagonist, in Japanese Patients With Acromegaly
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Clinical Pharmacokinetics
Pharmacology
Modulation of Growth Hormone Signal Transduction in Kidneys of Streptozotocin-Induced Diabetic Animals: Effect of a Growth Hormone Receptor Antagonist
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Antidepressant, Anxiolytic and Anorectic Effects of a Melanin-Concentrating Hormone-1 Receptor Antagonist
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Radiation Therapy and Toll-Like Receptor Signaling: Implications for the Treatment of Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology
The Orexin-1 Receptor Antagonist SB-334867 Blocks the Effects of Antipsychotics on the Activity of A9 and A10 Dopamine Neurons: Implications for Antipsychotic Therapy
Neuropsychopharmacology
Psychiatry
Mental Health
Pharmacology
Effects of a Growth Hormone-Releasing Hormone Antagonist on Telomerase Activity, Oxidative Stress, Longevity, and Aging in Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
